CaĆete, Alex D.
HRN: 25-85-81 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2024
CEFTAZIDIME 1GM (VIAL)
10/29/2024
11/12/2024
IV
2gm
Q8
Pseudomonas Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes